Evidence map›Paper›PMID 30998992›Full record

ArticleGastroenterology2019

High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.

Natasha Stephens Münch, Hsin-Yu Fang, Jonas Ingermann, H Carlo Maurer, Akanksha Anand, Victoria Kellner, Vincenz Sahm, Maria Wiethaler, Theresa Baumeister, Frederik Wein and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Targeting c-MET for Endoscopic Detection of Dysplastic Lesions within Barrett's Esophagus Using EMI-137 Fluorescence Imaging.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Predicting the potential deterioration of Barrett's esophagus based on gut microbiota: a Mendelian randomization analysis.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 10 institutions in 5 countries.

Natasha Stephens MünchDepartment of Internal Medicine, Technical University of Munich, Germany; Chair of Molecular Nutritional Medicine, Technical University of Munich, Germany.
Hsin-Yu FangDepartment of Internal Medicine, Technical University of Munich, Germany.
Jonas IngermannDepartment of Internal Medicine, Technical University of Munich, Germany; Chair of Molecular Nutritional Medicine, Technical University of Munich, Germany.
H Carlo MaurerDepartment of Internal Medicine, Technical University of Munich, Germany; Irvine Cancer Research Center, Columbia University, New York, New York.
Akanksha AnandDepartment of Internal Medicine, Technical University of Munich, Germany.
Victoria KellnerDepartment of Internal Medicine, Technical University of Munich, Germany.
Vincenz SahmDepartment of Internal Medicine, Technical University of Munich, Germany.
Maria WiethalerDepartment of Internal Medicine, Technical University of Munich, Germany.
Theresa BaumeisterDepartment of Internal Medicine, Technical University of Munich, Germany.
Frederik WeinDepartment of Internal Medicine, Technical University of Munich, Germany.
Henrik EinwächterDepartment of Internal Medicine, Technical University of Munich, Germany.
Florian BolzeChair of Molecular Nutritional Medicine, Technical University of Munich, Germany; EKFZ-Else Kröner-Fresenius Center for Nutritional Medicine, Technical University of Munich, Germany; ZIEL-Institute of Food & Health, Technical University of Munich, Germany.
Martin KlingensporChair of Molecular Nutritional Medicine, Technical University of Munich, Germany; EKFZ-Else Kröner-Fresenius Center for Nutritional Medicine, Technical University of Munich, Germany; ZIEL-Institute of Food & Health, Technical University of Munich, Germany.
Dirk HallerTechnical University of Munich, Germany.
Maria KavanaghDepartment of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.
Joanne LysaghtDepartment of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.
Richard FriedmanIrvine Cancer Research Center, Columbia University, New York, New York.
Andrew J DannenbergWeill Cornell Medical College, New York, New York.
Michael PollakMcGill University, Montreal, Quebec, Canada.
Peter R HoltRockefeller University, New York, New York.
Sureshkumar MuthupalaniMassachusetts Institute of Technology, Cambridge, Massachusetts.
James G FoxMassachusetts Institute of Technology, Cambridge, Massachusetts.
Mark T WharyMassachusetts Institute of Technology, Cambridge, Massachusetts.
Yoomi LeeIrvine Cancer Research Center, Columbia University, New York, New York.
Tony Y RenIrvine Cancer Research Center, Columbia University, New York, New York.
Rachael ElliotUniversity of California San Francisco, California.
Rebecca FitzgeraldCambridge University, Cambridge, UK.
Katja SteigerInstitute of Pathology, Technical University of Munich, Germany.
Roland M SchmidDepartment of Internal Medicine, Technical University of Munich, Germany.
Timothy C WangIrvine Cancer Research Center, Columbia University, New York, New York.
Michael QuanteDepartment of Internal Medicine, Technical University of Munich, Germany. Electronic address: michael.quante@tum.de.
Technical University of Munich · DECancer Research Center · USMassachusetts Institute of Technology · USElse Kröner-Fresenius-Stiftung · DETrinity College Dublin · IECornell University · USMcGill University · CARockefeller University · USUniversity of California, San Francisco · USUniversity of Cambridge · GB

Funding

Weight loss-induced Microbiome and Adipokine Changes in Barrett's EsophagusU54CA163004 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ABRAMS, JULIAN, RUSTGI, ANIL K · 2011 to 2022
$12.5M
NCI NIH HHS U54 CA163004
6 · The paper itself

Abstract

BACKGROUND &

aimsBarrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Progression from BE to cancer is associated with obesity, possibly due to increased abdominal pressure and gastroesophageal reflux disease, although this pathogenic mechanism has not been proven. We investigated whether environmental or dietary factors associated with obesity contribute to the progression of BE to EAC in mice.

methodsTg(ED-L2-IL1RN/IL1B)#Tcw mice (a model of BE, called L2-IL1B mice) were fed a chow (control) or high-fat diet (HFD) or were crossbred with mice that express human interleukin (IL) 8 (L2-IL1B/IL8 mice). Esophageal tissues were collected and analyzed for gene expression profiles and by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. Organoids were established from BE tissue of mice and cultured with serum from lean or obese individuals or with neutrophils from L2-IL1B mice. Feces from mice were analyzed by 16s ribosomal RNA sequencing and compared to 16s sequencing data from patients with dysplasia or BE. L2-IL1B were mice raised in germ-free conditions.

resultsL2-IL1B mice fed an HFD developed esophageal dysplasia and tumors more rapidly than mice fed the control diet; the speed of tumor development was independent of body weight. The acceleration of dysplasia by the HFD in the L2-IL1B mice was associated with a shift in the gut microbiota and an increased ratio of neutrophils to natural killer cells in esophageal tissues compared with mice fed a control diet. We observed similar differences in the microbiomes from patients with BE that progressed to EAC vs patients with BE that did not develop into cancer. Tissues from dysplasias of L2-IL1B mice fed the HFD contained increased levels of cytokines that are produced in response to CXCL1 (the functional mouse homolog of IL8, also called KC). Serum from obese patients caused organoids from L2-IL1B/IL8 mice to produce IL8. BE tissues from L2-IL1B mice fed the HFD and from L2-IL1B/IL8 mice contained increased numbers of myeloid cells and cells expressing Cxcr2 and Lgr5 messenger RNAs (epithelial progenitors) compared with mice fed control diets. BE tissues from L2-IL1B mice raised in germ-free housing had fewer progenitor cells and developed less dysplasia than in L2-IL1 mice raised under standard conditions; exposure of fecal microbiota from L2-IL1B mice fed the HFD to L2-IL1B mice fed the control diet accelerated tumor development.

conclusionsIn a mouse model of BE, we found that an HFD promoted dysplasia by altering the esophageal microenvironment and gut microbiome, thereby inducing inflammation and stem cell expansion, independent of obesity.

Indexed as

AdenocarcinomaAdultAgedAnimalsBarrett EsophagusCarcinogenesisDiet, High-FatDisease Models, AnimalDisease ProgressionEsophageal NeoplasmsEsophagusFecesFemaleGastrointestinal MicrobiomeHealthy VolunteersHumansCXCL8 protein, humanInterleukin-8cytokinesIL1BneutrophilsNK cells

Identifiers

PMID30998992
PMCPMC6662596
OpenAlexW2936849550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.